Glivin PM 2mg/500mg/15mg Tablet SR
Marketer
Aeon Remedies
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glivin PM 2mg/500mg/15mg Tablet SR
Combiflex SR tablets (2mg/500mg/15mg) are a triple-combination medication designed to manage blood glucose. This formulation, used alongside diet and exercise, enhances glycemic control in adults with type 2 diabetes. It facilitates improved insulin utilization, consequently reducing blood sugar. Always adhere to your physician's prescribed dosage and regimen for Combiflex SR. Taking it with food minimizes digestive discomfort. Missed doses should be taken promptly unless the next dose is imminent; in that case, omit the missed dose and resume the usual schedule. Never double the dose. An overdose can result in hypoglycemia. Concurrent use with other diabetes medications, alcohol consumption, or skipped meals increases the risk of hypoglycemia (low blood sugar). Regular blood glucose monitoring is crucial during treatment. Common adverse effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must also seek medical consultation. Kidney function assessment will be conducted before initiating therapy. Limit alcohol consumption as it may amplify the likelihood of side effects.
Primary Ingredients of Glivin PM 2mg/500mg/15mg Tablet SR
No information provided. Please provide the text you wish me to rephrase.
Uses of Glivin PM 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glivin PM 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glivin PM 2mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.
Common Side effects of Glivin PM 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glivin PM 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glivin PM 2mg/500mg/15mg Extended-Release Tablets should be administered with a meal.
How Glivin PM 2mg/500mg/15mg Tablet SR works:
Glivin PM 2mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity within the body.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glivin PM 2mg/500mg/15mg SR tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glivin PM 2mg/500mg/15mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glivin PM tablets (2mg/500mg/15mg) are likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glivin PM 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For individuals with severe kidney disease, this medication is contraindicated. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Exercise caution when prescribing Glivin PM 2mg/500mg/15mg SR tablets to individuals with hepatic impairment; dosage modification may be necessary. Patients with severe liver disease should not receive this medication. Physician consultation is advised.
What if you forget to take Glivin PM 2mg/500mg/15mg Tablet SR :
Should you forget to take your Glivin PM 2mg/500mg/15mg SR tablet, administer it immediately upon recollection. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Glivin PM 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently